The DOI matches its Crossref record; 95 of the 100 references it cites were found in a registry or an index.
Subclinical Cushing’s syndrome in adrenal incidentalomas
Abstract
This article reviews the available evidence on subclinical Cushing's syndrome in patients who have adrenal incidentalomas. The authors' aim is to present up-to-date information on the most relevant issues of subclinical Cushing's syndrome by addressing the many uncertainties and controversies surrounding this ill-defined endocrine condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the absence of florid signs and symptoms, ACS in patients AI has been associated with hypertension (215), insulin resistance (216), type 2 diabetes mellitus (217), obesity (218), metabolic syndrome (219), and increased mortality (75).”
From Adrenal incidentaloma (2020) · cites this paper as [215]
In the citing paper
“Focusing on glucose metabolism, the prevalence of IGT or DM has been higher in patients with SCS than in cases of nonfunctioning adenoma or controls (, , , , , , ), but these data were not confirmed by other studies that found much the same prevalence of these comorbidities in SCS as in the overall series of AI and in the general population (, -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [203]
In the citing paper
“in our and other authors' experience (1), the presence of signs and/or symptoms of cortisol excess is extremely rare in patients referred for the presence of an AI.”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“SH is estimated to be present in 5-30% of patients with adrenal masses serendipitously found by imaging for unrelated diseases [adrenal incidentalomas (AI)] (1,5).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“Similarly, LDDST has been used to diagnose SH (18,40,41,55) without advantages, with the exception of patients affected with alcoholism, psychiatric disorders, and diabetes in whom this test may be more accurate (1,14,66).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“The determination of ACTH levels after CRH does not seem to add any advantage (1,23,34,35,37,38,46) to screening for SH.”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“The reason to screen for SH with a higher cutoff than that recommended for overt cortisol excess [1.8 g/dl (50 nmol/liter)] (66) is that in patients without signs or symptoms suggestive of hypercortisolism, the a priori possibility of having SH is estimated to be lower than that of a false-positive result (1).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“Therefore, UFC should not be considered an adequate screening test for SH and should be used in combination with other tests or in specific populations (1,14).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“Although it may reflect an autonomous ACTH-independent cortisol hypersecretion, available data do not demonstrate that low DHEAS concentration is a reliable index of SH (1,23,35), also considering that DHEAS levels decrease with age (77).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“The main pitfall of these studies is that the increased uptake of the radiotracer may simply reflect the presence of enlarged adrenal tissue rather than an increased cortisol secretion (1,35,78).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
Citations
Cites
Malik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L'Italien, G. J., Pio, J. R., & Williams, G. R. (2004) · Circulation · doi:10.1161/01.cir.0000140677.20606.0e · Cited by 1,837
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · cited 1×
“Even if it is held that the metabolic syndrome is associated with enhanced all-cause and cardiovascular mortality [73,74], evidence of increased morbidity and mortality in patients who have clinically inapparent adrenal adenoma and subclinical Cushing’s syndrome or not, is lacking.”
BackgroundInsulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Self-citationManagement of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 7×
“The traditional threshold of 5 lg/dL (138 nmol/L) was recommended in the NIH consensus statement [ 2 ]; however, some experts proposed using lower cut points to increase the detection of subclinical hypercortisolism [55].”
BackgroundMethodInfluentialA Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Incidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
Flagged first, then by citations
5 of the 100 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–179 of 179
Mauclère-Denost, S., Duron-Martinaud, S., Nunes, M. L., Gatta‐Cherifi, B., Fagour, C., Rault, A., Gosse, P., & Tabarin, A. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.03.005 · Cited by 11
Virilizing Ovarian Leydig Cell Tumor in A Woman with Subclinical Cushing Syndrome
Diab, D., Faiman, C., SIPERSTEIN, A. E., Grossman, W., Rabinowitz, L., & Hamrahian, A. H. (2008) · Endocrine Practice · doi:10.4158/ep.14.3.358 · Cited by 11
Lechner, B., Heinrich, D. A., Nölting, S., Osswald-Kopp, A., Rubinstein, G., Sauerbeck, J., Beuschlein, F., & Reincke, M. (2018) · Der Internist · doi:10.1007/s00108-018-0505-3 · Cited by 10
Draft of the clinical practice guidelines “Adrenal incidentaloma”
Beltsevich, D. G., Troshina, E. A., Mel'nichenko, G. A., Platonova, N. M., Ladygina, D. O., & Chevais, A. (2021) · Endocrine Surgery · doi:10.14341/serg12712 · Cited by 10
Puglisi, S., Leporati, M., Amante, E., Parisi, A., Pia, A. R., Berchialla, P., Terzolo, M., Vincenti, M., & Reimondo, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.833514 · Cited by 10
Self-citationSulu, C., Koca, O., Icli, T. B., Öz, A., Kargın, O. A., Durcan, E., Şahin, S., Arslan, S., Turan, Ş., Kadıoğlu, P., et al. (2023) · Neuroradiology · doi:10.1007/s00234-023-03156-3 · Cited by 9
The role of confirmatory tests in the diagnosis of primary aldosteronism
Huang, C., Tu, K., Fan, K., Tsai, C., Wang, W., Wang, S., Wu, C.-Y., Hu, Y.-H., Huang, S.-H., Liu, H.-W., et al. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.04.022 · Cited by 9
Differential Diagnosis of Cushing’s Syndrome
Javorsky, B. R., Carroll, T. B., & Findling, J. W. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_7 · Cited by 9
Ognjanovic, S. I., Μacut, D., Petakov, M. S., Kovačević, V. E., Isailovic, T. V., Antić, I. B., Ilic, D. S., Popovic, B. M., Bogavac, T., Pekmezovic, T. D., et al. (2016) · Journal of Medical Biochemistry · doi:10.1515/jomb-2016-0020 · Cited by 9
Herrera-Martínez, A. D., Román, Á. R., Corrales, E. P., Idrobo, C., Ramírez, P. A. P., Rojas‐Marcos, P. M., Lázaro, C. R., Marginean, D. L., & Castro, M. A. (2023) · Cancers · doi:10.3390/cancers15194735 · Cited by 9
Natural course of benign adrenal incidentalomas in subjects with extra-adrenal malignancy
Yener, S., Ertilav, S., Seçil, M., Akıncı, B., Demir, T., Çömlekçi, A., & Yeşil, S. (2009) · Endocrine · doi:10.1007/s12020-009-9191-1 · Cited by 8
Vasilev, V., Matrozova, J., Elenkova, A. P., & Zacharieva, S. (2013) · Open Medicine · doi:10.2478/s11536-013-0199-9 · Cited by 7
Karaköse, M., Karbek, B., Şahi̇n, M., Arslan, M. S., Topaloğlu, O., Erden, G., Demirci, T., Çalışkan, M., & Delibaşı, T. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000008 · Cited by 7
In what clinical settings should Cushing's syndrome be suspected?
Bruno, O. D., Juárez‐Allen, L., Rossi, M., & Longobardi, V. (2009) · PubMed · Cited by 7
Tabarin, A., Bardet, S., Bertherat, J. Y., Chabre, O., Dupas, B., Hamoir, E., Laurent, F., Tenenbaum, F., Cazalda, M., Rohmer, V., et al. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.09.002 · Cited by 7
Persistent Comorbidities in Cushing’s Syndrome after Endocrine Cure
Resmini, E. (2014) · Advances in Endocrinology · doi:10.1155/2014/231432 · Cited by 7
Gianotti, L., Tassone, F., Pia, A. R., Bovio, S., Reimondo, G., Visconti, G., Terzolo, M., & Borretta, G. (2009) · Calcified Tissue International · doi:10.1007/s00223-009-9245-7 · Cited by 6
Self-citationBertholf, R. L., Jialal, I., & Winter, W. E. (2012) · Tietz Textbook of Clinical Chemistry and Molecular Diagnostics · doi:10.1016/b978-1-4160-6164-9.00054-8 · Cited by 5
Boyraz, A., Candemir, B., Akın, Ş., Candemir, M., & Gülçelik, N. E. (2025) · Annales d Endocrinologie · doi:10.1016/j.ando.2025.101687 · Cited by 5
Lee, J.-M., Kim, M. K., Ko, S., Koh, J., Kim, B., Kim, S.-W., Kim, S., Kim, H. J., Ryu, O., Park, J., et al. (2017) · Korean Journal of Medicine · doi:10.3904/kjm.2017.92.1.4 · Cited by 5
Screening Tests for Hypercortisolism in Patients With Adrenal Incidentaloma
Ferreira, L., Oliveira, J. C., & Palma, I. (2018) · Journal of Endocrinology and Metabolism · doi:10.14740/jem510w · Cited by 5
Adrenal Causes of Cushing’s Syndrome
Cavagnini, F., & Giraldi, F. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00103-7 · Cited by 5
Metabolic and cardiovascular impact of non-functioning adrenal adenomas: A clinical dilemma
Yener, S. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.02.005 · Cited by 5
D’Aurizio, F., Tozzoli, R., Dorizzi, R., Brescia, V., Esposito, E., Fortunato, A., Giovanella, L., & Guzzaloni, G. (2015) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.1007/s13631-015-0088-0 · Cited by 3
Adrenal Cortex Tumors and Hyperplasias
Pignatelli, D. (2011) · InTech eBooks · doi:10.5772/19108 · Cited by 4
Doença de cushing subclínica: relato de três casos e revisão da literatura
Silva, B. C. C., Baruqui, A. M., Barbosa, V. E., Pena, G. P., Campos, M. H. D. F., Ramos, A. V., & Dias, E. P. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000400018 · Cited by 4
Atar, R. V. (2020) · Northern Clinics of Istanbul · doi:10.14744/nci.2019.54771 · Cited by 4
Adrenal Incidentaloma Needs thorough Biochemical Evaluation – An Institutional Experience
Shah, A. N., Saikia, U. K., Chaudhary, B. K., & Bhuyan, A. K. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_335_21 · Cited by 4
Sandner, B., & Kratzsch, J. (2017) · Journal of Laboratory Medicine · doi:10.1515/labmed-2017-0024 · Cited by 4
Tercer Consenso Argentino sobre Patologías endocrinológicas
Boquete, H. (2009) · Revista Argentina de Endocrinología y Metabolismo · Cited by 3
Ognjanovic, S. I., Antic, J. A., Pekmezovic, T. D., Popovic, B. M., Isailovic, T. V., Antić, I. B., Bogavac, T., Kovačević, V. E., Ilic, D. S., Opalić, M., et al. (2021) · Maturitas · doi:10.1016/j.maturitas.2021.06.011 · Cited by 3
Síndrome de Cushing subclínica em populações de risco
Caetano, M. S. S., Vilar, L., & Kater, C. E. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800003 · Cited by 3
Laparoscopic adrenalectomy for co-secreting aldosterone and cortisol adenomas
Lobo, C., Kolinioti, A., Hainsworth, A. J., Bano, G., Mudan, S., & Sharma, A. D. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2012.08.017 · Cited by 3
Fang, Y. (2011) · International Journal of Urology · doi:10.1111/j.1442-2042.2011.02843.x · Cited by 3
Sandner, B., & Kratzsch, J. (2017) · Journal of Laboratory Medicine · doi:10.1515/labmed-2017-0004 · Cited by 2
A Case of Subclinical Cushing Syndrome and Multiple Myeloma
Kebapclar, L., Yeşil, S., Bayraktar, F., Demir, T., r, Z. G. N., lu, N. A., & i, A. M. (2007) · The Endocrinologist · doi:10.1097/01.ten.0000260862.09309.43 · Cited by 2
Hormonal evaluation of adrenal incidentalomas
Loupp, A.-G. L., Cariou, B., Drui, D., Graveline, N., Masson, D., & Bach‐Ngohou, K. (2014) · Annales de biologie clinique · doi:10.1684/abc.2014.1013 · Cited by 2
Case Report: Differentiating Obesity from Subclinical Cushing ’s Syndrome
(2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s11-003 · Cited by 2
Presentation and outcome of patients with an adrenal mass: A retrospective observational study
Nabi, T., Rafiq, N., Dar, S., & Rasool, S. (2020) · Clinical Cancer Investigation Journal · doi:10.4103/ccij.ccij_70_20 · Cited by 3
Modern capabilities of contrast-enhanced computed tomography in the diagnosis of adrenal adenomas
Tarbaeva, N. V., Chevais, A., Manaev, A. V., Beltsevich, D. G., Platonova, N. M., Troshina, E. A., Mel'nichenko, G. A., & Mokrysheva, N. G. (2026) · Problems of Endocrinology · doi:10.14341/probl13670 · Cited by 1
Allolio, B., Nies, C., Moll, R., Klose, K., Kann, P. H., Pfestroff, A., Waldmann, J., Bartsch, D. K., Lehnert, H., Dralle, H., et al. (2012) · Springer eBooks · doi:10.1007/978-3-642-14285-7_4 · Cited by 1
Relevance and perspective concept of investigation of subclinical Cushing syndrome.
Kuznetsov, N. S., Latkina, N. V., & Kaminarskaya, Y. A. (2016) · Endocrine Surgery · doi:10.14341/serg2016113-22 · Cited by 1
Terzolo, M. (2011) · doi:10.1093/med/9780199235292.003.0529 · Cited by 1
Self-citationCushing’s Disease: Diagnostic Evaluation
Findling, J. W., & Raff, H. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-264-9_10 · Cited by 1
Oliver, C. (2009) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(09)70553-7 · Cited by 1
Adrenal Incidentalomas and Arterial Hypertension
Παππά, Θ., Kaltsas, G., Piaditis, G. P., & Chrousos, G. P. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_6
ADRENAL INCIDENTALOMAS: DIAGNOSIS AND MANAGEMENT
Grineva, E. N., Belousova, L., & Basek, I. V. (2013) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2013-19-6-532-537
Adrenal Tumors in Older Persons
Carling, T., & Udelsman, R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6999-6_36
Guess the case from the ochsner clinic.
Brown, R. E., Scanlan, M. C., Burshell, A., & Richardson, W. S. (2007) · PubMed Central
A Cautionary Case: Adrenal Insufficiency after Unilateral Adrenalectomy for Adrenocortical Carcinoma
Player, H., Babkowski, R. C., & Dong, X. (2015) · World Journal of Endocrine Surgery · doi:10.5005/jp-journals-10002-1159
Small bowel adenocarcinoma mimicking a large adrenal tumor
Ivović, M., Zivaljevic, V. R., Vujović, S., Marina, L., Tančić‐Gajić, M., Dunđerović, D., Barać, M., & Micić, D. (2013) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1304232i
Adrenal Incidentalomas with Supraphysiologic Response to ACTH Stimulus: A Case Report
Antonopoulou, M., & Perelstein, A. (2012) · Case Reports in Endocrinology · doi:10.1155/2012/503290
Nam, K.-J., Kim, Y. J., Lee, S. Y., Lee, J. G., Cho, Y. H., Lee, Y.-H., Choi, E., Tak, Y. J., Yi, D., Park, S., et al. (2013) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2013.34.4.289
Hiperplasia adrenal macronodular bilateral ACTH independiente y síndrome de Cushing subclínico
Berdonces, M. C., Avilés-Pérez, M. D., García‐Martin, A., & Muñoz‐Torres, M. (2011) · Medicina Clínica · doi:10.1016/j.medcli.2011.05.003
Cushing's Syndrome Accompanied with Adrenal and Pancreatic Mass: A Case Report
Amouzegar, A., Ghanei, A., & Azizi, F. (2008) · Intern J Endocrinol Metab
Beato-Víbora, P. I., Ortega, P. R., & López, M. (2009) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2009.06.004
Ogo, A., Watanabe, A., Ide, C., Maruta, T., Sakai, Y., Hiramatsu, S., Uesugi, N., & Shigematsu, K. (2008) · PubMed · doi:10.15017/12487
L'incidentalome surrénalien, étude du statut métabolique et de la fibrinolyse
Thebert, J. (2015) · HAL
Adrenal Incidentaloma and Subclinical Hypercortisolism
Goddard, G. M., & Geer, E. B. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_22
Kang, M., Baek, M., Lee, J., & Jeong, B. C. (2017) · Journal of Urologic Oncology · doi:10.22465/kjuo.2017.15.3.137
Lechner, B., Heinrich, D. A., Nölting, S., Osswald-Kopp, A., Rubinstein, G., Sauerbeck, J., Beuschlein, F., & Reincke, M. (2019) · Zentralblatt für Arbeitsmedizin Arbeitsschutz und Ergonomie · doi:10.1007/s40664-019-0342-9
Subklinischer) Hyperkortisolismus als mögliche endokrine Hypertonieursache
Stepan, V. M. (2013)
Fornara, P., & Kawan, F. (2022) · Springer Reference Medizin · doi:10.1007/978-3-642-41168-7_31-2
Diagnostic and therapeutic management of patients with adrenal incidentaloma
Bajčetić, D., Tanasković, S., Sotirović, V., Jovanovic, M. C., Jovanović, P., Popov, P. A., Nenezić, D., Despotović, B., & Radak, Đ. (2015) · Medicinska istrazivanja · doi:10.5937/medist1501047b
Oliver, C. (2009) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(09)49738-2
Fornara, P., & Kawan, F. (2016) · Springer eBooks · doi:10.1007/978-3-642-39940-4_31
(2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000224813.85060.ab
Fornara, P., & Kawan, F. (2014) · Springer eBooks · doi:10.1007/978-3-642-41168-7_31-1
Nunes, M.-L., & Tabarin, A. (2011) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(11)53091-4
Fornara, P., & Kawan, F. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-63400-4_31
Adrenal incidentalomas: unresolved diagnostic issues
Annayev, M. S., Stegniy, K. V., Geltser, B. I., Goncharuk, R. A., & Morozova, A. M. (2023) · Pacific Medical Journal · doi:10.34215/1609-1175-2023-3-20-26
Incidentally Found Adrenal Masses: When Should We Worry?
Tritos, N. A. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.09.010
Progress in Subclinical Cushing’s Syndrome
赵, 陆. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122671
Zhang, J., Wu, P., Chen, Y., Wang, M., & Song, W. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1524121
Khan, T. A., Beigh, F. A., Khawaja, A. R., Malik, S. A., Para, S. A., Mehdi, S., Hamid, A., Verma, S. K., & Tantray, M. A. (2025) · Cureus · doi:10.7759/cureus.92389
Korkmaz, E. S., Gökçe, B. Ö., & Kebapçı, M. N. (2026) · Endocrine · doi:10.1007/s12020-026-04794-2
Metadata
- Authors
- Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G., & Angeli, A.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo (IT)
- Corresponding author
- Terzolo, Massimo
- Venue
- Endocrinology and Metabolism Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 34
- Issue
- 2
- Pages
- 423-439
- ISSN
- 0889-8529 (ISSN-L)
- OpenAlex
- W2065618767
- Cited by
- 179
- References
- 100
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 11 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 5 · 2017: 8 · 2016: 10 · 2015: 10 · 2014: 6 · 2013: 10 · 2012: 18
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology and Metabolism Clinics of North America (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- subclinical Cushing's syndrome, adrenal incidentaloma, adrenocortical hyperfunction, cortisol excess, adrenal adenoma
- MeSH terms
- Adrenal Cortex Neoplasms, Cushing Syndrome, Humans, Incidental Findings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
